We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App




Different Biochemical Parameters Found in Patients with IGR

By LabMedica International staff writers
Posted on 06 Aug 2019
Print article
Image: The Tosoh Automated Glycohemoglobin Analyzer G8, designed for rapid and reliable diabetic monitoring and diagnosis (Photo courtesy of Tosoh).
Image: The Tosoh Automated Glycohemoglobin Analyzer G8, designed for rapid and reliable diabetic monitoring and diagnosis (Photo courtesy of Tosoh).
Diabetes is a chronic metabolic disease due either to a lack of insulin secretion or reduced insulin sensitivity, with high blood sugar levels being the main characteristic and is often associated with fat, protein and electrolyte metabolic disorders and acid-base imbalance.

The risk of heart, brain or renal vascular disease is three to five times higher in diabetes patients than in normal subjects. Previous studies have shown that major vascular complications are already evident even in subjects with blood glucose levels under the limit for the diagnosis of diabetes.

Endocrinologists at the Ninth Hospital of Xi’an (Xian Shi, China) recruited total of 354 participants study including 174 in the type 2 diabetes (T2DM) group, 112 in the impaired glucose regulation (IGR) group and 68 in the normal glucose tolerance (NGT) group. Fasting blood samples were taken from all participants to measure various biochemical parameters. All indexes were monitored at 30 minutes, 60 minutes, 120 minutes and 180 minutes after subjects had orally taken 75 g glucose, a three-hour oral glucose tolerance test (OGTT).

The team measured HbA1c (%) in fresh blood samples containing EDTA by using high-performance liquid chromatography on the Tosoh Automated Glycohemoglobin Analyzer. Blood glucose (BG), total cholesterol (TC), triglyceride (TG), high-density lipoprotein cholesterol (HDL-C), and low-density lipoprotein cholesterol (LDL-C) were analyzed enzymatically by using an Auto Biochemical Analyzer. Insulin and C-peptide (CP) were measured with a Roche Cobas 6000 Automatic Electrochemical Luminescence Analyzer.

The investigators reported that the basic overall HbA1c serum concentration percentages were 5.52%, 6.33% and 9.76% for the NTG, IGR and T2DM cases. During the OGTT, insulin secretion in the IGR group was almost double that of the T2DM group. CP levels were highest in the IGR patients and OGTT related BG concentrations were highest in the T2DM group followed by IGR, but in the IGR group hyperglycemia was less pronounced than in T2DM patients. Compared to the NGT group, TC, TG and LDL-C serum concentrations were significantly higher and HDL-C concentrations were significantly lower in IGR and T2DM cases compared to the NTG group.

The authors concluded that in an OGTT, insulin and C-peptide serum concentrations were higher in the IGR than in the T2DM and NGT groups. In addition, TC, TG and LDL-C were all significantly higher and HDL-C values significantly lower in the IGR and T2DM groups compared to the NGT group. The study was published on July 15, 2019, in the journal BMC Endocrine Disorders.

Related Links:
Ninth Hospital of Xi’an

Gold Member
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Verification Panels for Assay Development & QC
Seroconversion Panels
New
Alpha-Fetoprotein Reagent
AFP Reagent Kit
New
Cytomegalovirus Test
NovaLisa Cytomegalovirus (CMV) IgG Test

Print article

Channels

Molecular Diagnostics

view channel
Image: Health Canada has approved SPINEstat, a first-in-class diagnostic blood test for axSpA, as a Class II medical device (Photo courtesy of Augurex)

First-in-Class Diagnostic Blood Test Detects Axial Spondyloarthritis

Axial spondyloarthritis (axSpA) is a chronic inflammatory autoimmune condition that typically affects individuals during their most productive years, with symptoms often emerging before the age of 45.... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Technology

view channel
Image: The new algorithms can help predict which patients have undiagnosed cancer (Photo courtesy of Adobe Stock)

Advanced Predictive Algorithms Identify Patients Having Undiagnosed Cancer

Two newly developed advanced predictive algorithms leverage a person’s health conditions and basic blood test results to accurately predict the likelihood of having an undiagnosed cancer, including ch... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.